Atorvastatin/amlodipine

The drug combination atorvastatin/amlodipine (trade names Caduet in the US, Australia and Russia, and Envacar elsewhere) is a medication approved by the Food and Drug Administration (FDA) for the treatment of high cholesterol and high blood pressure. It is a fixed-dose combination drug containing a HMG-CoA reductase inhibitor and a calcium channel blocker being marketed by the pharmaceutical company Pfizer.[1][2]

Atorvastatin/amlodipine
Combination of
AmlodipineCalcium channel blocker
AtorvastatinStatin
Clinical data
Pregnancy
category
  • US: X (Contraindicated)
    Routes of
    administration    		By mouth
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • In general: ℞ (Prescription only)
    Identifiers
    PubChem CID
    ChemSpider
      (verify)

    References
    1. "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. February 2010. Retrieved 2010-09-25.
    2. Devabhaktuni, Madhuri; Bangalore, Sripal (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–387. doi:10.2147/vhrm.s3339. ISSN 1178-2048. PMC 2686256. PMID 19475775.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.